Stay updated on Cabozantinib for Merkel Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.

Latest updates to the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe revision label on the page changed from v3.6.4 to v3.6.5, signaling a small deployment or patch rather than content updates.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision updated from v3.6.3 to v3.6.4, indicating a minor update to the page version. There are no changes to the study content or results.SummaryDifference0.1%

- Check55 days agoChange DetectedThe revision label on the page was updated from v3.6.2 to v3.6.3, indicating a new build/version deployment of the page.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s revision label was updated from v3.6.0 to v3.6.2, indicating a minor update to the page template.SummaryDifference0.1%

- Check76 days agoChange DetectedThe study record now indicates that enrollment has ended ('No longer looking for participants') and adds new help/navigation sections: 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. It also shows a UI text formatting change for 'Intervention/Treatment' and updates the revision banner from v3.5.5 to v3.6.0.SummaryDifference0.6%

- Check83 days agoChange DetectedThe page footer revision label updated from v3.5.4 to v3.5.5, indicating a newer site revision.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Merkel Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Merkel Cell Carcinoma Clinical Trial page.